Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)
Hong Kong · Delayed Price · Currency is HKD 2.420
-0.020 (-0.82%)
Apr 24, 2026, 3:51 PM HKT
HKG:8049 Revenue
In the year 2025, Jilin Province Huinan Changlong Bio-pharmacy Company had annual revenue of 901.87M CNY with 2.35% growth. Jilin Province Huinan Changlong Bio-pharmacy Company had revenue of 463.00M in the half year ending December 31, 2025, with 3.83% growth.
Revenue
901.87M CNY
Revenue Growth
+2.35%
P/S Ratio
1.35
Revenue / Employee
814.70K CNY
Employees
1,107
Market Cap
1.36B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 901.87M | 20.71M | 2.35% |
| Dec 31, 2024 | 881.16M | 39.61M | 4.71% |
| Dec 31, 2023 | 841.55M | -41.00K | - |
| Dec 31, 2022 | 841.59M | 136.13M | 19.30% |
| Dec 31, 2021 | 705.46M | 83.21M | 13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chia Tai Enterprises International | 4.17B |
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Essex Bio-Technology | 1.81B |
| Jacobson Pharma Corporation | 1.53B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Dawnrays Pharmaceutical (Holdings) | 1.37B |
| Golden Throat Holdings Group Company | 1.05B |
| JBM (Healthcare) | 812.98M |